Search Results - "Lachâtre, Marie"
-
1
Safety and immunogenicity of a measles-vectored SARS-CoV-2 vaccine candidate, V591 / TMV-083, in healthy adults: results of a randomized, placebo-controlled Phase I study
Published in EBioMedicine (01-01-2022)“…V591 (TMV-083) is a live recombinant measles vector-based vaccine candidate expressing a pre-fusion stabilized SARS-CoV-2 spike protein. We performed a…”
Get full text
Journal Article -
2
A national platform for Covid-19 vaccine studies recruitment in France: Covireivac volunteer's characteristics
Published in Human vaccines & immunotherapeutics (30-11-2022)“…During the Covid-19 pandemic, the urgent need for safe and effective vaccines has led to many vaccine trials, implying fast and extensive recruitment of…”
Get full text
Journal Article -
3
A French cohort for assessing COVID-19 vaccine responses in specific populations
Published in Nature Medicine (01-08-2021)Get full text
Journal Article Magazine Article -
4
Immunogenicity and Safety of Beta-Adjuvanted Recombinant Booster Vaccine
Published in The New England journal of medicine (28-07-2022)“…In a small trial of boost immunization with the mRNA vaccine originally received or with heterologous boosting with spike proteins from the original strain or…”
Get full text
Journal Article -
5
Long-term outcome and safety of prolonged bedaquiline treatment for multidrug-resistant tuberculosis
Published in The European respiratory journal (01-03-2017)“…Bedaquiline, a recently approved drug for the treatment of multidrug-resistant tuberculosis (MDR-TB), is recommended for a duration of 24 weeks. There are…”
Get full text
Journal Article -
6
Bedaquiline plus delamanid for XDR tuberculosis
Published in The Lancet infectious diseases (01-03-2016)“…The combination was initiated in a patient in whom an effective treatment cannot be designed, in the consideration that its potential life-saving benefits…”
Get full text
Journal Article -
7
Reduced bone mineral density among HIV-infected, virologically controlled young men: prevalence and associated factors
Published in AIDS (London) (28-11-2018)“…OBJECTIVE:Reduced bone mineral density (BMD) is a frequent comorbidity observed in people living with HIV (PLHIV). We aimed to determine the prevalence of…”
Get full text
Journal Article -
8
HIV and hypogonadism: a new challenge for young-aged and middle-aged men on effective antiretroviral therapy
Published in AIDS (London) (28-01-2017)“…Male hypogonadism is poorly defined in people living with HIV. Using a reliable free-testosterone assay, we examined the prevalence and risk factors of male…”
Get full text
Journal Article -
9
Hypogonadism: a neglected comorbidity in young and middle-aged HIV-positive men on effective combination antiretroviral therapy
Published in AIDS (London) (01-07-2022)“…Objective: Male hypogonadism is poorly characterized in young-to-middle-aged people with HIV (PWH). We used a reliable free testosterone assay to assess the…”
Get full text
Journal Article -
10
Clinical characteristics, risk factors, and outcome of tuberculosis in kidney transplant recipients: A multicentric case‐control study in a low‐endemic area
Published in Transplant infectious disease (01-10-2018)“…Objectives Tuberculosis (TB) is a rare but life‐threatening infection after solid organ transplant. The present study was undertaken to assess the clinical…”
Get full text
Journal Article -
11
Immunogenicity and reactogenicity of heterologous and homologous mRNA-1273 and BNT162b2 vaccination: A multicenter non-inferiority randomized trial
Published in EClinicalMedicine (01-06-2022)“…Although effective mRNA vaccines for SARS-CoV-2 infection have been deployed worldwide, their interchangeability could facilitate the scale-up of vaccination…”
Get full text
Journal Article -
12
Prevention and management of VZV infection during pregnancy and the perinatal period
Published in Infectious diseases now (Online) (01-06-2024)“…[Display omitted] •A chickenpox is more severe in pregnant women than in adults; it exposes the unborn child to three risks: congenital varicella syndrome,…”
Get full text
Journal Article -
13
Hypogonadism: a neglected comorbidity in young and middle-aged HIV-positive men on effective cART
Published in AIDS (London) (01-02-2022)“…Male hypogonadism (MH) is poorly characterized in young-to-middle-aged people living with HIV (PLHIV). We used a reliable free testosterone (FT) assay to…”
Get full text
Journal Article -
14
Reduced bone mineral density among HIV-infected, virologically controlled young men
Published in AIDS (London) (28-11-2018)Get full text
Journal Article -
15
1954. Immunogenicity against SARS CoV-2 ancestral strain and variants of two new COVID-19 recombinant adjuvanted vaccines compared to BNT162b2 as a third dose following two doses of BNT162b2: a single-blinded multicenter randomized controlled trial
Published in Open forum infectious diseases (15-12-2022)“…Abstract Background New adjuvanted recombinant protein vaccines against coronavirus disease 2019 (COVID-19) as heterologous boosters could maximize the…”
Get full text
Journal Article -
16
Quantifying preferences around vaccination against frequent, mild disease with risk for vulnerable persons: A discrete choice experiment among French hospital health care workers
Published in Vaccine (29-01-2021)“…•First DCE to study the drivers of health care workers’ vaccination intentions.•Poor vaccine safety has the most detrimental impact on stated…”
Get full text
Journal Article -
17
Exclusive oral antibiotic treatment for hospitalized community-acquired pneumonia: a post-hoc analysis of a randomized clinical trial
Published in Clinical microbiology and infection (01-08-2024)“…In this study, we aimed to assess the efficacy of different ways of administration and types of beta-lactams for hospitalized community-acquired pneumonia…”
Get more information
Journal Article -
18
Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019
Published in Euro surveillance : bulletin européen sur les maladies transmissibles (21-02-2019)“…Influenza A(H1N1)pdm09 and A(H3N2) viruses both circulated in Europe in October 2018-January 2019. Interim results from six studies indicate that 2018/19…”
Get full text
Journal Article -
19
Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 years
Published in Scientific reports (27-11-2022)“…Abstract Immune response induced by COVID-19 vaccine booster against delta and omicron variants was assessed in 65 adults (65–84 years old) early aftesr a…”
Get full text
Journal Article -
20
Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 years
Published in Scientific reports (27-11-2022)“…Immune response induced by COVID-19 vaccine booster against delta and omicron variants was assessed in 65 adults (65–84 years old) early aftesr a first booster…”
Get full text
Journal Article